Search results for '**' (4 products)

4 Item(s)

06 May 2020  |  South Asia, Middle East & North Africa

Understanding the Impact of COVID-19 on the GCC Region

An Assessment of Growth Opportunities and Growth Pipelines in Light of the Pandemic

Like other economies, countries in the GCC have been rendered vulnerable by the COVID-19 pandemic. Wholesale and retail trade, transportation and storage, and finance and insurance, which accounted for nearly 50Percentage of Dubai’s gross domestic product (GDP) in 2018, have all been affected. In the oil and gas industry, plunging jet fuel demand...

USD 7,500.00
27 Apr 2020  |  Global

COVID-19 Growth Impact Assessment for the Automotive Industry, 2020

Stakeholders to Focus on Resource Optimization, New Growth Segments and Cost Rationalization to Overcome Slowdown

The mushrooming corona virus outbreak in the central Chinese city of Wuhan prompted the World Health Organization (WHO) to declare a global health emergency in late January. The corona virus outbreak isn’t just a massive health crisis; it’s an economic one as well. If the pandemic is not contained by a large extent by April, the drop in consum...

USD 7,500.00
02 Apr 2020  |  Global

Top 50 Emerging Technologies & Growth Opportunities - Interactive Deliverable Access

Multi-billion Dollar Technologies Transforming the Global Economy and Our Future

The TechVision team focuses on researching emerging technologies, innovations, and the disruptive convergence of technologies resulting in new growth opportunities and solutions to global challenges. TechVision‘s annual 'Top 50 Emerging Technologies’ research delivers cutting-edge intelligence about the 50 most valuable and disruptive techn...

USD 12,000.00
10 Jan 2020  |  Asia Pacific

Growth Insights on China’s Pharmaceutical Industry, Forecast to 2025

Expedited Regulatory Reviews, Accompanied by Surging Novel Drug Pipelines and a Realigned Distribution System will Propel the Chinese Pharma Industry

With over-4000 pharmaceutical players, China is the second largest pharmaceutical industry globally. Although highly fragmented, global pharma and biopharmaceutical players such as Novartis, Novo Nordisk, and AstraZeneca, have a significant hold capturing at least 8-10Percentage of the market. The market being highly dependent on its distributor ne...

USD 10,000.00

4 Item(s)